Skip to search formSkip to main contentSkip to account menu

Byetta

National Institutes of Health

Related topics

Related topics

2 relations
60 ACTUAT exenatide 0.005 MG/ACTUAT Pen Injector [Byetta]

Broader (1)

exenatide

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
[Effect of byetta on renal osmoregulatory function in patients with diabetes mellitus].
The renal osmoregulatory function was studied in patients with type 2 diabetes mellitus (DM). The renal response to water loading… 
2014
2014
Effect of byetta on renal osmoregulatory function in patients with diabetes mellitus
The renal osmoregulatory function was studied in patients with type 2 diabetes mellitus (DM). The renal response to water loading… 
Review
2013
Review
2013
Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists Drug Class Review
2011
2011
Gates eyes biotechs as for-profit investments
2010
2010
Deal watch: Metabolex and Sanofi–Aventis partner on GPCR agonists for type 2 diabetes
2009
2009
Bye-bye WilBio
volume 27 number 8 august 2009 nature biotechnology to its improved pharmacokinetic/pharmacodynamic profile: Victoza is injected… 
2009
2009
Byetta label changed to include renal failure warnings
  • 2009
  • Corpus ID: 195168673
2008
2008
[Exenatide (Byetta)].
2006
2006
Exenatide ( Byetta ) , an Incretin Mimetic : The First in a New Therapeutic Class in the Treatment of Diabetes
258 P&T® • May 2006 • Vol. 31 No. 5 INTRODUCTION Diabetes is a growing problem in the U.S. In 2002, it was estimated that 18.2… 
2006
2006
Exenatide Injection (Byetta): Adjunctive Therapy for Glycemic Control
Exenatide is an injectable treatment for type 2 diabetes. Its use requires patient education and strict monitoring of glucose… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)